LONDON-Oxford BioMedica Plc, a gene therapy company spun from Oxford University, has announced they are making progress in an anti-cancer vaccine.
TroVax, designed to stimulate a patient's immune system to destroy cancer cells, has been tested in phase1/11 studies. Patients involved in the study did develop an immune response against a tumor antigen in colorectal cancer. The vaccine works by encoding the protein OBA1, which naturally exists on the surface of many tumor cells, and basically teaching the immune system to fight these protein cells when they are recognized.
People involved in the study were divided into three dosage groups of the vaccine. The first study's results are from the low dosage group, with the other reports expected to be published next year.
While officials from the company are optimistic the vaccine will be successful, they also warn that it has not yet been shown to treat human cancer.
Information from www.givenimaging.com, Reuters Health
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.